Question 1

What triggers angiogenesis in rapidly growing tissues?

Accepted Answer

Angiogenesis is triggered by hypoxia, a state of low oxygen levels in rapidly growing embryos, tumors, and wounded tissues. Under hypoxic conditions, the transcription factor HIF-1 accumulates and induces expression of vascular endothelial growth factor (VEGF) and other angiogenic factors. This initiates the formation of new blood vessels to restore oxygen supply to the affected tissue.

Question 2

How does HIF-1 regulate gene expression during hypoxia?

Accepted Answer

Under hypoxic conditions, HIF-1 alpha accumulates in the cytosol and translocates to the nucleus, where it binds HIF-1 beta to form a dimer. This dimer associates with the CBP/P300 transcriptional regulator and binds HIF response elements on target genes, initiating their transcription. Under normal oxygen levels, HIF-1 alpha is hydroxylated and degraded by proteasomal enzymes, stopping this process.

Question 3

What is the role of VEGF in endothelial cell differentiation?

Accepted Answer

VEGF is a dimeric protein that binds transmembrane receptors called VEGF receptors on endothelial cells. VEGF-A, the most important isoform, stimulates endothelial cells to differentiate into specialized tip cells. These tip cells then express delta-like notch ligand four (DLL4), which signals neighboring cells to differentiate into stalk cells that support vessel formation.

Question 4

How do tip cells and stalk cells coordinate during angiogenesis?

Accepted Answer

Tip cells express high levels of DLL4, which binds Notch receptors on neighboring cells and signals them to proliferate and differentiate into stalk cells. The endothelial tip cell migrates following the VEGF gradient toward hypoxic tissues, while stalk cells provide structural support. This coordinated differentiation allows new blood vessels to extend and reach oxygen-depleted areas.

Question 5

What stabilizes newly formed blood vessels after angiogenesis?

Accepted Answer

Angiopoietin-1 binding to Tie-2 receptors promotes endothelial cell survival, initiates vascular branching, and stabilizes newly formed vessels. Additionally, junctional proteins like VE-cadherins, N-cadherins, and occludin stabilize the endothelial lining. Protease inhibitors prevent matrix degradation, helping maintain vessel integrity once formation is complete.

Question 6

How does oxygen restoration stop angiogenesis?

Accepted Answer

Once blood flows through newly formed vessels and oxygen levels increase in the tissue, proteasomal enzymes degrade HIF-1 alpha. This stops VEGF expression and inhibits further angiogenesis. The mechanism of angiogenesis is thus tightly regulated by oxygen availability, ensuring blood vessel formation occurs only when needed.

Question 7

What role do matrix metalloproteases play in angiogenesis?

Accepted Answer

Matrix metalloproteases degrade the basement membrane and extracellular matrix, allowing endothelial tip cells to migrate toward hypoxic target tissues. This enzymatic degradation is essential for vessel formation. Once the vessel is formed and stabilized, protease inhibitors prevent further matrix degradation, maintaining the structural integrity of the newly formed blood vessel.

혈관 신생 및 혈액 공급 조절

Browse More Videos